According to GuruFocus insider data, the following are the largest CEO buys in the past week.
American Assets Trust CEO bought 327,544 shares
American Assets Trust Inc. (AAT, Financial) Chairman, CEO, President, and 10% Owner Ernest S. Rady bought 327,544 shares at a price of $32.79.
American Assets Trust is a self-administered Real Estate Investment Trust (REIT) based in the U.S. The company mainly invests in, operates and develops retail, office, residential and mixed-use properties in California, Oregon and Hawaii. The company has a market cap of $2.14 billion. Its shares traded at $33.22 with a price-earnings ratio of 53.41 as of March 16.
Net income for the fourth quarter of 2017 was $9.73 million compared to $12.41 million for the prior-year period.
Rady bought 64,775 shares on Feb. 27 at a price of $32.56; 132,240 shares on Mar. 2 at a price of $31.71; 104,715 shares on Mar. 7 at a price of $32.21; 67,961 shares on Mar. 9 at a price of $32.2; and 259,583 shares on Mar. 14 at a price of $32.95. The price of the stock has increased by 0.82% since.
REV Group CEO bought 100,000 shares
REV Group Inc. (REVG, Financial) CEO Timothy W. Sullivan bought 100,000 shares on Mar. 13 at a price of $22.53. The price of the stock has decreased by 6.57% since.
REV Group is a designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. It serves a diversified customer base in the United States through three segments, Fire and Emergency, Commercial, and Recreation. The company has a market cap of $1.36 billion. Its shares traded at $21.05 with a price-earnings ratio of 25.86 as of Mar. 16.
Net income for the first quarter of 2018 was $9.4 million compared to a net loss of $13.3 million for the first quarter of 2017.
OPKO Health CEO bought 153,500 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman, and 10% Owner Phillip Frost bought 153,500 shares at a price of $3.36.
OPKO is a diversified health care company. Its business includes diagnostics and provision of pharmaceutical products. The company has a market cap of $2.01 billion. Its shares traded at $3.60 as of March 16.
Consolidated revenue for the quarter ended Dec. 31 was $193.7 million compared to $275.5 million for the prior-year period.
Frost bought 75,000 shares on Mar. 7 at a price of $3.29; 32,000 shares on Mar. 8 at a price of $3.28; 25,000 shares on Mar. 12 at a price of $3.48; 67,500 shares on Mar. 13 at a price of $3.36; and 61,000 shares on Mar. 15 at a price of $3.32. The price of the stock has increased by 8.43% since.
Senior Vice President and Chief Financial Officer Adam Logal bought 2,065 shares on Mar. 13 at a price of $3.4. The price of the stock has increased by 5.88% since.
Executive Vice President of Administration Steven D. Rubin bought 6,000 shares on Mar. 7 at a price of $3.25. The price of the stock has increased by 10.77% since.
Valeant Pharmaceuticals International CEO bought 30,000 shares
Valeant Pharmaceuticals International Inc. (VRX, Financial) Chairman and CEO Joseph C. Papa bought 30,000 shares on Mar. 13 at a price of $16.05. The price of the stock has increased by 4.24% since.
Valeant Pharmaceuticals International is a specialty pharmaceutical and medical device company which develops, manufactures and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices. The company has a market cap of $5.84 billion. Its shares traded at $16.73 with a price-earnings ratio of 2.45 as of Mar. 16.
Total revenue for the fourth quarter of 2017 was $2.16 billion compared to $2.40 billion in the fourth quarter of 2016.
Executive Vice President and Chief Financial Officer Paul Herendeen bought 15,000 shares on Mar. 13 at a price of $16.1. The price of the stock has increased by 3.91% since.
Director Richard U. DeSchutter bought 10,000 shares on Mar. 8 at a price of $15.34. The price of the stock has increased by 9.06% since.
Director John Paulson (Trades, Portfolio) bought 7,066,629 shares on Mar. 6 at a price of $15.4. The price of the stock has increased by 8.64% since.
Select Energy Services CEO bought 29,388 shares
Select Energy Services Inc. (WTTR, Financial) President and CEO Holli C. Ladhani bought 29,388 shares on Mar. 14 at a price of $13.87. The price of the stock has decreased by 1.37% since.
Select Energy Services is a provider of water solutions. Its solutions include Water Solutions, Well Testing, Fluid Handling, and Disposal Solutions. The company has a market cap of $1.45 billion. Its shares traded at $13.68 as of Mar. 16.
Net loss for the fourth quarter of 2017 was $14.9 million compared to net loss of $24.7 million in the fourth quarter of 2016.
On Nov. 1, 2017, Select Energy Services announced that it completed its stock-for-stock merger with Rockwater Energy Solutions.
Director Richard Alan Burnett bought 2,500 shares on Mar. 13 at a price of $14.14. The price of the stock has decreased by 3.25% since.
For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
